Juvenile dermatomyositis: advances in clinical presentation, myositis-specific antibodies and treatment

[1] Meyer A(2015)Incidence and prevalence of inflammatory myopathies: a systematic review Rheumatology (Oxford) 54 50-63

[2] Meyer N(2013)The clinical phenotypes of the juvenile idiopathic inflammatory myopathies Medicine (Baltimore) 92 25-41

[3] Schaeffer M(2002)Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes Rheum Dis Clin North Am 28 833-857

[4] Gottenberg JE(2011)Comparison of clinical features and drug therapies among European and Latin American patients with juvenile dermatomyositis Clin Exp Rheumatol 29 117-124

[5] Geny B(2006)The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland) -clinical characteristics of children recruited within the first 5 years Rheumatology (Oxford) 45 1255-1260

[6] Sibilia J(2014)Clinical characteristics of children with juvenile dermatomyositis: the Childhood Arthritis and Rheumatology Research Alliance Registry Arthritis Care Res (Hoboken) 66 404-410

[7] Shah M(2005)History of infection before the onset of juvenile dermatomyositis: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry Arthritis Rheum 53 166-172

[8] Mamyrova G(2018)Clinical signs and symptoms in a joint model of four disease activity parameters in juvenile dermatomyositis: a prospective, longitudinal, multicenter cohort study Arthritis Res Ther. 20 180-740

[9] Targoff IN(2014)Early illness features associated with mortality in the juvenile idiopathic inflammatory myopathies Arthritis Care Res (Hoboken) 66 732-3592

[10] Huber AM(2008)Predicting the course of juvenile dermatomyositis: significance of early clinical and laboratory features Arthritis Rheum 58 3585-904

[1] Meyer A(2015)Incidence and prevalence of inflammatory myopathies: a systematic review Rheumatology (Oxford) 54 50-63

[2] Meyer N(2013)The clinical phenotypes of the juvenile idiopathic inflammatory myopathies Medicine (Baltimore) 92 25-41

[3] Schaeffer M(2002)Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes Rheum Dis Clin North Am 28 833-857

[4] Gottenberg JE(2011)Comparison of clinical features and drug therapies among European and Latin American patients with juvenile dermatomyositis Clin Exp Rheumatol 29 117-124

[5] Geny B(2006)The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland) -clinical characteristics of children recruited within the first 5 years Rheumatology (Oxford) 45 1255-1260

[6] Sibilia J(2014)Clinical characteristics of children with juvenile dermatomyositis: the Childhood Arthritis and Rheumatology Research Alliance Registry Arthritis Care Res (Hoboken) 66 404-410

[7] Shah M(2005)History of infection before the onset of juvenile dermatomyositis: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry Arthritis Rheum 53 166-172

[8] Mamyrova G(2018)Clinical signs and symptoms in a joint model of four disease activity parameters in juvenile dermatomyositis: a prospective, longitudinal, multicenter cohort study Arthritis Res Ther. 20 180-740

[9] Targoff IN(2014)Early illness features associated with mortality in the juvenile idiopathic inflammatory myopathies Arthritis Care Res (Hoboken) 66 732-3592

[10] Huber AM(2008)Predicting the course of juvenile dermatomyositis: significance of early clinical and laboratory features Arthritis Rheum 58 3585-904